CXCL10 and ovarian cancer: Therefore, we generated four independent cohorts that covered the most common microarray platforms, ultimately elucidating the comprehensive landscape of CXCL10 in ovarian cancer clinical outcomes, TME characteristics, and underlying mechanisms.